THE / USDC

THE / USDT

THE / TRY

ETHFI / USDC

ETHFI / USDT

ETHFI / TRY

TFUEL / BTC

DEXE / USDT

SAHARA / USDC

SAHARA / USDT

DEGO / USDT

FRAX / USDT

SXP / TRY

BARD / TRY

BARD / USDT

BARD / USDC

YB / TRY

YB / USDT

IDEX / USDT

YB / USDC

USHA FINANCIAL SERVICES L

MMTC LIMITED

VALIANT ORGANICS LIMITED

JBM AUTO LIMITED

JAY BEE LAMINATIONS LTD

SURANI STEEL TUBES LTD.

DCM SHRIRAM INTERNATNL L

UTSSAV CZ GOLD JEWELS LTD

BHARAT ROAD NETWORK LTD

DODLA DAIRY LIMITED

JFL LIFE SCIENCES LTD

FALCON TECHNOPROJ IND LTD

DEE DEVELOPMENT ENG LTD

GACM TECHNOLOGIES LIMITED

BALAJI PHOSPHATES LIMITED

OIL COUNTRY TUBULAR LTD.

KHFM HOS FAC MANA SER LTD

GREENLEAF ENVIROTECH LTD

DIENSTEN TECH LIMITED

SRIVASAVI ADHESIVE TAPE L

Click here to get full coverage on Glenmark wins FDA approval for fluticasone propionate aerosol inhaler - World Aerosols

Glenmark wins FDA approval for fluticasone propionate aerosol inhaler  World Aerosols

Glenmark wins FDA approval for fluticasone propionate aerosol inhaler - World Aerosols

Click here to get full coverage on Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity - PR Newswire

Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity  PR Newswire

Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity - PR Newswire

Click here to get full coverage on Glenmark to Launch First Generic Version of Flovent HFA - Medical Professionals Reference

Glenmark to Launch First Generic Version of Flovent HFA  Medical Professionals Reference

Glenmark to Launch First Generic Version of Flovent HFA - Medical Professionals Reference

Click here to get full coverage on Five Stocks To Buy: IIFL Finance, Mahindra And Mahindra, Laurus Labs, Glenmark Pharma And More - MSN

Five Stocks To Buy: IIFL Finance, Mahindra And Mahindra, Laurus Labs, Glenmark Pharma And More  MSN

Five Stocks To Buy: IIFL Finance, Mahindra And Mahindra, Laurus Labs, Glenmark Pharma And More - MSN

Click here to get full coverage on The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year - ProPublica

The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year  ProPublica

The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year - ProPublica

Click here to get full coverage on FDA gives Glenmark thumbs-up for first 'true' generic version of GSK's asthma inhaler Flovent - Fierce Pharma

FDA gives Glenmark thumbs-up for first 'true' generic version of GSK's asthma inhaler Flovent  Fierce Pharma

FDA gives Glenmark thumbs-up for first 'true' generic version of GSK's asthma inhaler Flovent - Fierce Pharma

Click here to get full coverage on Glenmark Pharmaceuticals USA to launch Potassium Phosphates injection USP - Express Pharma

Glenmark Pharmaceuticals USA to launch Potassium Phosphates injection USP  Express Pharma

Glenmark Pharmaceuticals USA to launch Potassium Phosphates injection USP - Express Pharma

Click here to get full coverage on Glenmark Pharmaceuticals Inc to Launch Potassium Phosphates Injection USP in the US - Machine Maker

Glenmark Pharmaceuticals Inc to Launch Potassium Phosphates Injection USP in the US  Machine Maker

Glenmark Pharmaceuticals Inc to Launch Potassium Phosphates Injection USP in the US - Machine Maker

Click here to get full coverage on Stock Radar: Glenmark Pharma breaks out from a range to hit fresh record high in March 2026; what should i - The Economic Times

Stock Radar: Glenmark Pharma breaks out from a range to hit fresh record high in March 2026; what should i  The Economic Times

Stock Radar: Glenmark Pharma breaks out from a range to hit fresh record high in March 2026; what should i - The Economic Times

Click here to get full coverage on India's Glenmark posts higher quarterly profit on strong demand in N.America, Europe - Reuters

India's Glenmark posts higher quarterly profit on strong demand in N.America, Europe  Reuters

India's Glenmark posts higher quarterly profit on strong demand in N.America, Europe - Reuters

Click here to get full coverage on Ichnos Glenmark Innovation (IGI) Appoints Dr Lida Pacaud as Interim Chief Executive Officer - Oncodaily

Ichnos Glenmark Innovation (IGI) Appoints Dr Lida Pacaud as Interim Chief Executive Officer  Oncodaily

Ichnos Glenmark Innovation (IGI) Appoints Dr Lida Pacaud as Interim Chief Executive Officer - Oncodaily

Click here to get full coverage on Glenmark in $1B deal for Hengrui's HER2-targeted antibody-drug conjugate - FirstWord Pharma

Glenmark in $1B deal for Hengrui's HER2-targeted antibody-drug conjugate  FirstWord Pharma

Glenmark in $1B deal for Hengrui's HER2-targeted antibody-drug conjugate - FirstWord Pharma

Click here to get full coverage on Glenmark Pharma: HSBC sees 21% upside after ‘first-to-market’ US FDA win - The Financial Express

Glenmark Pharma: HSBC sees 21% upside after ‘first-to-market’ US FDA win  The Financial Express

Glenmark Pharma: HSBC sees 21% upside after ‘first-to-market’ US FDA win - The Financial Express

Click here to get full coverage on Glenmark bags multi-regional rights to Hansoh Pharma’s oncology drug for $1 B - BioSpectrum Asia

Glenmark bags multi-regional rights to Hansoh Pharma’s oncology drug for $1 B  BioSpectrum Asia

Glenmark bags multi-regional rights to Hansoh Pharma’s oncology drug for $1 B - BioSpectrum Asia

Click here to get full coverage on Glenmark Specialty Enters $1 Billion Exclusive License Agreement with Hengrui for Trastuzumab Rezetecan - Pharmaceutical Executive

Glenmark Specialty Enters $1 Billion Exclusive License Agreement with Hengrui for Trastuzumab Rezetecan  Pharmaceutical Executive

Glenmark Specialty Enters $1 Billion Exclusive License Agreement with Hengrui for Trastuzumab Rezetecan - Pharmaceutical Executive

Click here to get full coverage on Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe - PR Newswire

Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe  PR Newswire

Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe - PR Newswire

Click here to get full coverage on In potential $1.1B deal, Glenmark grabs certain rights to Hengrui's ADC rival to Enhertu - Fierce Pharma

In potential $1.1B deal, Glenmark grabs certain rights to Hengrui's ADC rival to Enhertu  Fierce Pharma

In potential $1.1B deal, Glenmark grabs certain rights to Hengrui's ADC rival to Enhertu - Fierce Pharma

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial - PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial  PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial - PR Newswire

Click here to get full coverage on AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody - PR Newswire

AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody  PR Newswire

AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody - PR Newswire

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials - PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials  PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials - PR Newswire

Click here to get full coverage on Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter - Fierce Pharma

Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter  Fierce Pharma

Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter - Fierce Pharma

Click here to get full coverage on Glenmark set to join peers in 'Semaglutide' push - The Economic Times

Glenmark set to join peers in 'Semaglutide' push  The Economic Times

Glenmark set to join peers in 'Semaglutide' push - The Economic Times

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) Single-Dose Vials - PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) Single-Dose Vials  PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) Single-Dose Vials - PR Newswire

Click here to get full coverage on FDA warns Glenmark for failure to investigate dissolution failures - Regulatory Affairs Professionals Society | RAPS

FDA warns Glenmark for failure to investigate dissolution failures  Regulatory Affairs Professionals Society | RAPS

FDA warns Glenmark for failure to investigate dissolution failures - Regulatory Affairs Professionals Society | RAPS

Click here to get full coverage on Glenmark Appoints Former Mankind Pharma Leader Kamlesh Gupta as Business Head - Medical Dialogues

Glenmark Appoints Former Mankind Pharma Leader Kamlesh Gupta as Business Head  Medical Dialogues

Glenmark Appoints Former Mankind Pharma Leader Kamlesh Gupta as Business Head - Medical Dialogues

Click here to get full coverage on India's Glenmark Pharma soars 10% to record high on AbbVie cancer treatment licensing deal - Reuters

India's Glenmark Pharma soars 10% to record high on AbbVie cancer treatment licensing deal  Reuters

India's Glenmark Pharma soars 10% to record high on AbbVie cancer treatment licensing deal - Reuters

Click here to get full coverage on Glenmark Pharmaceuticals of NJ recalls blood pressure medication - Bergen Record

Glenmark Pharmaceuticals of NJ recalls blood pressure medication  Bergen Record

Glenmark Pharmaceuticals of NJ recalls blood pressure medication - Bergen Record

Click here to get full coverage on AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B - BioSpace

AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B  BioSpace

AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B - BioSpace

Click here to get full coverage on Glenmark launches epinephrine injection - Drug Store News

Glenmark launches epinephrine injection  Drug Store News

Glenmark launches epinephrine injection - Drug Store News

Click here to get full coverage on AbbVie to pay $700M for trispecific drug from Ichnos Glenmark - BioPharma Dive

AbbVie to pay $700M for trispecific drug from Ichnos Glenmark  BioPharma Dive

AbbVie to pay $700M for trispecific drug from Ichnos Glenmark - BioPharma Dive

Click here to get full coverage on Glenmark to launch generic sodium phosphates injection in US - ET Pharma

Glenmark to launch generic sodium phosphates injection in US  ET Pharma

Glenmark to launch generic sodium phosphates injection in US - ET Pharma

Click here to get full coverage on Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial) - PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial)  PR Newswire

Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial) - PR Newswire

Click here to get full coverage on AbbVie steps up for Glenmark's multispecific | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

AbbVie steps up for Glenmark's multispecific | ApexOnco - Clinical Trials news and analysis  Oncology Pipeline

AbbVie steps up for Glenmark's multispecific | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Click here to get full coverage on India's Glenmark Pharma unit, AbbVie sign exclusive licensing pact - Reuters

India's Glenmark Pharma unit, AbbVie sign exclusive licensing pact  Reuters

India's Glenmark Pharma unit, AbbVie sign exclusive licensing pact - Reuters

Click here to get full coverage on Blood pressure medication recalled for potential cross-contamination, reports say - WTOC

Blood pressure medication recalled for potential cross-contamination, reports say  WTOC

Blood pressure medication recalled for potential cross-contamination, reports say - WTOC

Click here to get full coverage on Cosmo y Glenmark anuncian la autorización de comercialización de Winlevi® - PR Newswire

Cosmo y Glenmark anuncian la autorización de comercialización de Winlevi®  PR Newswire

Cosmo y Glenmark anuncian la autorización de comercialización de Winlevi® - PR Newswire

Click here to get full coverage on Glenmark Pharma shares soar 2% on plans to launch potassium phosphates injection USP - Upstox

Glenmark Pharma shares soar 2% on plans to launch potassium phosphates injection USP  Upstox

Glenmark Pharma shares soar 2% on plans to launch potassium phosphates injection USP - Upstox

Click here to get full coverage on Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer - PR Newswire

Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer  PR Newswire

Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer - PR Newswire

Click here to get full coverage on Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) - PR Newswire

Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)  PR Newswire

Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) - PR Newswire

Click here to get full coverage on AbbVie pays $700M upfront for trispecific rival to J&J, Pfizer in blood cancer - Fierce Biotech

AbbVie pays $700M upfront for trispecific rival to J&J, Pfizer in blood cancer  Fierce Biotech

AbbVie pays $700M upfront for trispecific rival to J&J, Pfizer in blood cancer - Fierce Biotech

Click here to get full coverage on Fierce Pharma Asia—Celltrion's Lilly plant buy; Rexulti's PTSD snub; Glenmark, Hengrui's ADC deal - Fierce Pharma

Fierce Pharma Asia—Celltrion's Lilly plant buy; Rexulti's PTSD snub; Glenmark, Hengrui's ADC deal  Fierce Pharma

Fierce Pharma Asia—Celltrion's Lilly plant buy; Rexulti's PTSD snub; Glenmark, Hengrui's ADC deal - Fierce Pharma

Click here to get full coverage on GLENMARK Outlook for the Week (March 16, 2026 – March 20, 2026) - Equitypandit

GLENMARK Outlook for the Week (March 16, 2026 – March 20, 2026)  Equitypandit

GLENMARK Outlook for the Week (March 16, 2026 – March 20, 2026) - Equitypandit

Click here to get full coverage on Glenmark secures multi-regional rights for Hansoh’s lung cancer drug Aumolertinib - ET Pharma

Glenmark secures multi-regional rights for Hansoh’s lung cancer drug Aumolertinib  ET Pharma

Glenmark secures multi-regional rights for Hansoh’s lung cancer drug Aumolertinib - ET Pharma

Click here to get full coverage on Top stock picks: Analysts bullish on Infosys, Dixon, PFC, Glenmark, Eternal - CNBC TV18

Top stock picks: Analysts bullish on Infosys, Dixon, PFC, Glenmark, Eternal  CNBC TV18

Top stock picks: Analysts bullish on Infosys, Dixon, PFC, Glenmark, Eternal - CNBC TV18

Click here to get full coverage on Q1 Results Updates: Vodafone Idea Loss Narrows; Patanjali, Glenmark Pharma Profit Slides - MSN

Q1 Results Updates: Vodafone Idea Loss Narrows; Patanjali, Glenmark Pharma Profit Slides  MSN

Q1 Results Updates: Vodafone Idea Loss Narrows; Patanjali, Glenmark Pharma Profit Slides - MSN

Click here to get full coverage on Glenmark launches olopatadine HCl 0.2% to US market - Eyes On Eyecare

Glenmark launches olopatadine HCl 0.2% to US market  Eyes On Eyecare

Glenmark launches olopatadine HCl 0.2% to US market - Eyes On Eyecare

Click here to get full coverage on Glenmark Pharmaceuticals Stock Drops 3.8% Amid Mixed Analyst Views and High Valuation Concerns - AD HOC NEWS

Glenmark Pharmaceuticals Stock Drops 3.8% Amid Mixed Analyst Views and High Valuation Concerns  AD HOC NEWS

Glenmark Pharmaceuticals Stock Drops 3.8% Amid Mixed Analyst Views and High Valuation Concerns - AD HOC NEWS

Click here to get full coverage on An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients - ProPublica

An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients  ProPublica

An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients - ProPublica

Click here to get full coverage on Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhaler - The Economic Times

Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhaler  The Economic Times

Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhaler - The Economic Times

Click here to get full coverage on Glenmark launches Epinephrine Injection USP multiple-dose vial in the US - Express Pharma

Glenmark launches Epinephrine Injection USP multiple-dose vial in the US  Express Pharma

Glenmark launches Epinephrine Injection USP multiple-dose vial in the US - Express Pharma

Click here to get full coverage on Glenmark Pharmaceuticals Stock Dips 3.8% Amid Mixed Analyst Views and Strong Fundamentals - AD HOC NEWS

Glenmark Pharmaceuticals Stock Dips 3.8% Amid Mixed Analyst Views and Strong Fundamentals  AD HOC NEWS

Glenmark Pharmaceuticals Stock Dips 3.8% Amid Mixed Analyst Views and Strong Fundamentals - AD HOC NEWS

Click here to get full coverage on Glenmark strikes $1 Bn cancer drug licensing deal with Chinese drugmaker - ET Pharma

Glenmark strikes $1 Bn cancer drug licensing deal with Chinese drugmaker  ET Pharma

Glenmark strikes $1 Bn cancer drug licensing deal with Chinese drugmaker - ET Pharma

Click here to get full coverage on Should you buy Glenmark Pharma, JB Chemicals shares after recent highs? Here’s what Kiran Jani says - Business Today

Should you buy Glenmark Pharma, JB Chemicals shares after recent highs? Here’s what Kiran Jani says  Business Today

Should you buy Glenmark Pharma, JB Chemicals shares after recent highs? Here’s what Kiran Jani says - Business Today

Click here to get full coverage on Glenmark Pharmaceuticals Limited Just Beat Revenue By 16%: Here's What Analysts Think Will Happen Next - simplywall.st

Glenmark Pharmaceuticals Limited Just Beat Revenue By 16%: Here's What Analysts Think Will Happen Next  simplywall.st

GLENMARK

Price Chart

Key Statistics

Technicals

About GLENMARK

Latest News

Glenmark wins FDA approval for fluticasone propionate aerosol inhaler - World Aerosols

Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity - PR Newswire

Glenmark to Launch First Generic Version of Flovent HFA - Medical Professionals Reference

Advanced Charts

Top Gainers

Top Losers